SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001047469-15-007854
Filing Date
2015-10-14
Accepted
2015-10-14 17:19:28
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-1/A a2226181zf-1a.htm F-1/A 3362319
2 EX-1.1 a2226181zex-1_1.htm EX-1.1 244975
3 EX-23.1 a2226181zex-23_1.htm EX-23.1 4111
4 EX-23.2 a2226181zex-23_2.htm EX-23.2 4259
5 EX-23.3 a2226181zex-23_3.htm EX-23.3 3406
6 G400376.JPG g400376.jpg GRAPHIC 20191
7 G456181.JPG g456181.jpg GRAPHIC 121631
8 G815679.JPG g815679.jpg GRAPHIC 42419
9 G715597.JPG g715597.jpg GRAPHIC 34175
10 G454757.JPG g454757.jpg GRAPHIC 17289
11 G852078.JPG g852078.jpg GRAPHIC 30729
  Complete submission text file 0001047469-15-007854.txt   3987927
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: F-1/A | Act: 33 | File No.: 333-206654 | Film No.: 151158682
SIC: 2834 Pharmaceutical Preparations